Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Document Type
Year range
1.
Biomedica ; 42, 2022.
Article in Spanish | Web of Science | ID: covidwho-2068070

ABSTRACT

Introduction: Since the first report in Wuhan (China) in 2019, the SARS-CoV 2 virus has spread throughout the world, with a significant impact in public health. To contain the spread of SARS-CoV-2, the WHO has encouraged the development of rapid, simple, sensitive and specific tests that complement the gold standard RT-qPCR. Loop-mediated isothermal amplification (LAMP) has shown a good yield to detect SARS-CoV2 in different fluids. Objective: To validate the colorimetric RT-LAMP technique using two sets of oligonucleotides aimed at identifying the N gene of SARS-CoV-2 in 117 nasopharyngeal swab samples, previously confirmed by RT-qPCR using the Charite/Berlin protocol. Material and methods: 153 nasopharyngeal swab samples from individuals with suspected Covid-19 were subjected to qRT-PCR and RT-LAMP using a commercial colorimetric kit (NEB, Germany). RT-LAMP was run using both extracted RNA samples and raw samples without prior RNA extraction, and the result was assessed by a simple color change in the reaction. Results: RT-LAMP sensibility and specificity for gen N SARS-CoV-2 detection using one primers set previosly reported got values 0.97 (0.85, 1.00) and 0.81 (0.65, 0.92) respectively, for CI 95%. The other set primer used in this paper also reported previosly had 0.96 (0.78,1.00) sensibility and 0.77 (0.55,0.92) specificity to RT-LAMP. Without RNA extraction we found sensibility value of 0.95 (0.74, 1.00) and specificity 0.88 (0.64, 0.99). Conclusion: Taking together, the obtained results show RT-LAMP technique could be considered a rapid diagnostic test, easy to perform, free of sophisticated equipment, sensitive and specific to diagnose SARS-CoV-2 in nasopharyngeal swabs with and without prior RNA extraction, which that allows scaling its portability to places with scarce sources of resources.

2.
Francis, J. M.; Leistritz-Edwards, D.; Dunn, A.; Tarr, C.; Lehman, J.; Dempsey, C.; Hamel, A.; Rayon, V.; Liu, G.; Wang, Y.; Wille, M.; Durkin, M.; Hadley, K.; Sheena, A.; Roscoe, B.; Ng, M.; Rockwell, G.; Manto, M.; Gienger, E.; Nickerson, J.; Moarefi, A.; Noble, M.; Malia, T.; Bardwell, P. D.; Gordon, W.; Swain, J.; Skoberne, M.; Sauer, K.; Harris, T.; Goldrath, A. W.; Shalek, A. K.; Coyle, A. J.; Benoist, C.; Pregibon, D. C.; Jilg, N.; Li, J.; Rosenthal, A.; Wong, C.; Daley, G.; Golan, D.; Heller, H.; Sharpe, A.; Abayneh, B. A.; Allen, P.; Antille, D.; Armstrong, K.; Boyce, S.; Braley, J.; Branch, K.; Broderick, K.; Carney, J.; Chan, A.; Davidson, S.; Dougan, M.; Drew, D.; Elliman, A.; Flaherty, K.; Flannery, J.; Forde, P.; Gettings, E.; Griffin, A.; Grimmel, S.; Grinke, K.; Hall, K.; Healy, M.; Henault, D.; Holland, G.; Kayitesi, C.; LaValle, V.; Lu, Y.; Luthern, S.; Schneider, J. M.; Martino, B.; McNamara, R.; Nambu, C.; Nelson, S.; Noone, M.; Ommerborn, C.; Pacheco, L. C.; Phan, N.; Porto, F. A.; Ryan, E.; Selleck, K.; Slaughenhaupt, S.; Sheppard, K. S.; Suschana, E.; Wilson, V.; Carrington, M.; Martin, M.; Yuki, Y.; Alter, G.; Balazs, A.; Bals, J.; Barbash, M.; Bartsch, Y.; Boucau, J.; Carrington, M.; Chevalier, J.; Chowdhury, F.; DeMers, E.; Einkauf, K.; Fallon, J.; Fedirko, L.; Finn, K.; Garcia-Broncano, P.; Ghebremichael, M. S.; Hartana, C.; Jiang, C.; Judge, K.; Kaplonek, P.; Karpell, M.; Lai, P.; Lam, E. C.; Lefteri, K.; Lian, X.; Lichterfeld, M.; Lingwood, D.; Liu, H.; Liu, J.; Ly, N.; Hill, Z. M.; Michell, A.; Millstrom, I.; Miranda, N.; O'Callaghan, C.; Osborn, M.; Pillai, S.; Rassadkina, Y.; Reissis, A.; Ruzicka, F.; Seiger, K.; Sessa, L.; Sharr, C.; Shin, S.; Singh, N.; Sun, W.; Sun, X.; Ticheli, H.; Trocha-Piechocka, A.; Walker, B.; Worrall, D.; Yu, X. G.; Zhu, A..
Sci Immunol ; : eabk3070, 2021.
Article in English | PubMed | ID: covidwho-1519187

ABSTRACT

[Figure: see text].

SELECTION OF CITATIONS
SEARCH DETAIL